Avita Medical (RCEL)
(Delayed Data from NSDQ)
$10.41 USD
-0.16 (-1.51%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $10.43 +0.02 (0.19%) 5:10 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Avita Medical Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -35.38 | -26.67 | -14.43 | -26.58 | -42.03 |
Depreciation/Amortization & Depletion | 0.63 | 0.57 | 0.33 | 0.72 | 0.47 |
Net Change from Assets/Liabilities | -6.57 | -1.20 | 4.68 | -7.36 | 1.33 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 3.31 | 8.20 | 3.92 | 7.32 | 17.49 |
Net Cash From Operating Activities | -38.01 | -19.09 | -5.50 | -25.90 | -22.75 |
Property & Equipment | -1.38 | -0.45 | -0.07 | -0.89 | -0.59 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 3.05 | -18.81 | -49.55 | 0.00 | NA |
Other Investing Activities | -0.07 | -0.07 | -0.07 | -0.28 | -0.26 |
Net Cash from Investing Activities | 1.61 | -19.33 | -49.68 | -1.17 | -0.85 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.61 | 0.90 | 0.01 | 69.17 | 82.18 |
Issuance (Repayment) of Debt | 38.76 | 0.00 | 0.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | -0.01 | -0.04 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | 0.00 | -5.11 | -5.08 |
Net Cash from Financing Activities | 40.37 | 0.90 | 0.01 | 64.05 | 77.06 |
Effect of Exchange Rate Changes | -0.02 | -0.03 | -0.06 | 0.13 | 0.00 |
Net Change In Cash & Equivalents | 3.95 | -37.55 | -55.24 | 37.11 | 53.47 |
Cash at Beginning of Period | 18.16 | 55.71 | 110.95 | 73.84 | 20.37 |
Cash at End of Period | 22.12 | 18.16 | 55.71 | 110.95 | 73.84 |
Diluted Net EPS | -27.93 | -21.33 | -1.17 | -23.45 | -41.41 |
Fiscal Year End for Avita Medical Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -34.05 | -18.66 | -35.38 | -28.32 | -19.60 |
Depreciation/Amortization & Depletion | 0.41 | 0.20 | 0.63 | 0.45 | 0.28 |
Net Change from Assets/Liabilities | -6.30 | -6.25 | -6.57 | -6.58 | -3.67 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.30 | 3.84 | 3.31 | 7.30 | 4.82 |
Net Cash From Operating Activities | -33.64 | -20.86 | -38.01 | -27.15 | -18.17 |
Property & Equipment | -3.80 | -1.15 | -1.38 | -1.09 | -0.58 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 31.38 | 16.30 | 3.05 | 60.03 | 37.76 |
Other Investing Activities | -0.08 | -0.08 | -0.07 | -0.03 | -0.02 |
Net Cash from Investing Activities | 27.50 | 15.07 | 1.61 | 58.91 | 37.15 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.48 | 0.63 | 1.61 | 0.94 | 0.34 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 38.76 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 1.48 | 0.63 | 40.37 | 0.94 | 0.34 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | -0.02 | -0.02 | 0.00 |
Net Change In Cash & Equivalents | -4.67 | -5.17 | 3.95 | 32.69 | 19.32 |
Cash at Beginning of Period | 22.12 | 22.12 | 18.16 | 18.16 | 18.16 |
Cash at End of Period | 17.45 | 16.95 | 22.12 | 50.85 | 37.49 |
Diluted Net EPS | -12.00 | -14.55 | -5.53 | -6.80 | -8.20 |